Analogic — Jefferies 2017 Healthcare Conference
36 slides from Analogic's conference presentation, Jun 7, 2017
Slide 1: Jefferies 2017 Healthcare Conference
50 Jefferies 2017 Healthcare Conference Mark Frost, SVP and Cfo June 8, 2017 years of imaging innovation Exhibit 99.1
Slide 2: Safe Harbor
Safe Harbor Any statements about future expectations, plans, and prospects for the Company, including statements containing the words “believes,” “anticipates,” “plans,” “expects,” and similar expressions, constitute forward-looking statements within the meaning of the Private Securities Litigation
Slide 3: Use of Non-GAAP Financial Measures
This presentation includes non-GAAP financial measures that are not in accordance with, nor an alternative to, generally accepted accounting principles and may be different from such non-GAAP measures used by other companies. In addition, these non-GAAP measures are not based on any comprehensive se
Slide 4: Years of Imaging Innovation
50 Years of Imaging Innovation Founded in 1967 Advancing image guidance technology for medical and security Global research, engineering, and operations Fiscal 2016 Highlights: $509 million revenue $3.54 Non-GAAP* EPS Operating cash of $33 million, Free cash flow** of $20 million 1,500 employees wor
Slide 5: Our Imaging Technology Drives Innovative Products
Our Imaging Technology Drives Innovative Products Material Science Signal and image processing Precision A/D conversion Precision RF/Power Amplification Imaging & Guidance “Core Technologies” “Critical Imaging Chain” Mammo Ultrasound Probes High voltage power supplies High power amplifiers Pulsed RF
Slide 6: Our Business Segments
Our Business Segments Medical Imaging Ultrasound Security & Detection 57% of revenues* 32% of revenues* 11% of revenues* Increase content with OEMs Leverage common platforms Drive growth in emerging markets Focus in Urology and Surgery Expand into General Imaging with technology partner Exploit oppo
Slide 7: Moving to the Next Level of Performance
Moving to the Next Level of Performance Non-GAAP operating margin and non-GAAP EPS figures exclude certain charges; please refer to the non-GAAP reconciliation table in the back of this presentation. Inconsistent results in recent years requires renewed focus
Slide 8: Ultrasound
ULTRASOUND
Slide 9: Focused Ultrasound Market Opportunities
Focused Ultrasound Market Opportunities Global Ultrasound Market 2016 ($6.2 billion) 1 POC – Point of care 2 EMED: Emergency Medicine Revenue Growth Rate by Application (’15-’20) BK Ultrasound Markets ($700M) Partner Markets ($3B) Source: IHS May 2017 Technology Partnerships Focused Approach Served
Slide 10: Ultrasound Portfolio Optimization
Ultrasound Portfolio Optimization Surgical Guidance bk5000 Urology bk3000 General Imaging Partnerships Point of Care Anesthesia/EMED bk3500 Upside opportunities
Slide 11: Ultrasound: Turnaround Opportunity
Ultrasound: Turnaround Opportunity Sales growth has not matched our pace of investment Focus on optimizing portfolio and improving operating profit in FY18 and future Balance sheet clean-up actions resulting in non-cash charges FY17 estimates are based on mid-point of range Non-GAAP operating margin
Slide 12: Medical Imaging
Medical Imaging
Slide 13: Guidance in Medical Imaging
Guidance in Medical Imaging Computed Tomography Digital Mammography Magnetic Resonance
Slide 14: Increasing Value with Full Systems
Increasing Value with Full Systems Data Acquisition Subsystem Detection Management Subsystem Power & Data Management CT Imaging engine Image Reconfiguration GE OPTIMA NM/CT 640 Accuray TomoTherapy Anke 16-Slice CT
Slide 15: Ruggedized CT Gantry Progressing
Qinghai Xinjiang Inner Mongolia Tibet Guizhou Zhejiang Fujian Gansu Ningxia Shanxi Shanxi Hebei Heilongjiang Jilin Liaoning Shandong Jiangsu Henan Anhui Hubei Hunan Jiangxi Yunnan Sichuan Chongqing Guangxi Guangdong Ruggedized CT Gantry Progressing Beijing > 185 systems installed
Slide 16: Magnetic Resonance Power Sub-systems
Magnetic Resonance Power Sub-systems RF Amplifier Gradient Amplifier Enabled 3T wide bore systems Common platforms and modular design Design wins with new market entrants
Slide 17: Digital Mammography Detector Sub-Systems
Digital Mammography Detector Sub-Systems Analogic Enables Best Detection Superior Se Based Technology Premium 3D tomo performance Lower dose with best image quality Fastest Image acquisition US installed base of 2D is ~ 11,000 systems, more than 5000 are 7+ years Replacement cycle is moving to 3D
Slide 18: Medical Imaging: Solid Profitability
Medical Imaging: Solid Profitability OEM sourcing decisions effect short term revenue growth in FY17 and FY18 Margin improvement driven by product/customer mix and cost initiatives FY17 estimates are based on mid-point of range Non-GAAP operating margin and non-GAAP EPS figures exclude certain charg
Slide 19: Security and Detection
Security and Detection
Slide 20: Checked Baggage Opportunities with Leading OEMs
Checked Baggage Opportunities with Leading OEMs North America Replacement Demand 1800 sockets TSA extended EDS life from 10 to 15 years to prepare for next gen purchases Canada completing purchases of high-speed EDS systems Europe and Middle East Increasing Momentum 2000 sockets Early adoption under
Slide 21: Checkpoint CT Under Evaluation
Checkpoint CT Under Evaluation ConnectCT accepted into TSA laboratory for formal certification testing; International certification testing in early 2017 Commercial trials with CT in Europe validated a 2X operational improvement with over 1.3 million bags scanned while improving detection ConnectCT
Slide 22: Upside in Rapid DNA
Upside in Rapid DNA DNA profile generated in under 84 minutes vs. weeks in federal labs Significant market opportunity for law enforcement and government agencies FBI NDIS (National DNA Index System) approval achieved for domestic 4-color version Evaluation currently underway for new global standard
Slide 23: Security and Detection: Strong Op. Leverage
Security and Detection: Strong Op. Leverage Revenue growth driven by international high speed tenders and upside with Checkpoint CT and RapidDNA FY17 estimates are based on mid-point of range Non-GAAP operating margin and non-GAAP EPS figures exclude certain charges; please refer to the non-GAAP rec
Slide 24: Financial Outlook
F SIPINANCIAL =. OUTLOOK
Slide 25: Financial Outlook
Financial Outlook Fiscal 2017 - Expect low to mid-single digit revenue declines with non-GAAP operating margin between 8.5% and 9.5% resulting in non-GAAP diluted EPS of between $2.40 and $2.70 FY17 estimates are based on mid-point of range Non-GAAP operating margin and non-GAAP EPS figures exclude
Slide 26: Strong Balance Sheet and Consistent Cash Flows
Strong Balance Sheet and Consistent Cash Flows 1 As of July 31, 2015 Includes $12MM tax refund $159M1 of cash/investments with no long term debt - YTD operating cash flow of $54M, Free cash flow of $46M Capital allocation through ongoing investment, M&A and share re-purchase $15 million share repurc
Slide 27: Strategic Options for Improved Value Creation
Strategic Options for Improved Value Creation Board of Directors has directed that all strategic options be considered to accelerate the pace of value creation for our shareholders Update to these options, as well as an update to FY18 guidance, will be given on or before the Q4 FY17 earnings call 1
Slide 28: Thank You
Thank You OVERVIEW
Slide 29: Appendix
Appendix OVERVIEW
Slide 30: Q3 FY17 Financial Highlights
Q3 FY17 Financial Highlights Revenue and Profitability In-Line * Non-GAAP operating margin/income figures exclude certain charges; please refer to the non-GAAP reconciliation table in the back of this presentation and in Analogic’s Q3 FY 2017 earnings release available at http://investor.analogic.co
Slide 31: Revenue and Non-GAAP Operating Margin Trend
FY16 FY17 Revenue $M and Non-GAAP* Operating Margin Trend Non-GAAP Operating Margin* Non-GAAP OM 16% 21% 18% 20% 12% 20% 21% GAAP OM 10% 16% 14% 17% 10% 17% 18% 10% 9% 19% 16% 18% 15% 17% 2% -2% 14% 11% 17% 9% 14% FY17 FY16 -5% 7% -5% 4% -11% -2% -14% -13% -23% -13% -2% -16% -11% -228% Q3 FY17 Opera
Slide 32: Working Capital and Cash Flow
Working Capital and Cash Flow (Amounts may not foot due to rounding to millions) Operating cash flow of $13M in Q3, Cap Ex at $2M resulting in Free cash flow of $11M YTD operating cash flow of $53M and Free cash flow of $46M Accounts receivables up sequentially on timing of shipments Inventory flat
Slide 33: FY 2017 Outlook
FY 2017 Outlook FY17 – Expect mid-single digit revenue declines with non-GAAP operating margin between 8.5% - 9.5%; non-GAAP diluted EPS of between $2.40 and $2.70 Ultrasound: High-single digits revenue declines with negative low double digit op margin Restructuring actions will disrupt FY17 with lo
Slide 34: Non-GAAP Reconciliation
Non-Gaap Reconciliation Gi \ OVERVIEW analogic” ‘
Slide 35: Non-GAAP Statements of Operations Reconciliation
NON-GAAP ST’ ME (hn thousands, excopt per share data) GAAP Income From Operation: Rost ‘Acquistion rolated revenues and expenses Non-GAAP Income From Operations Percentage of Total Net Revenue GAAP Other income (Expen: don BK Medical distrbutor mattor inquiry related costs ‘Acquisition rolated reven
Slide 36: Non-GAAP Statements of Operations Reconciliation
NON-GAAP STATEMENTS OF OPERATIONS RECONCILIATION (h thousands, except per share data) ‘Twelve months Ended July 34,2012 July 34,2013 July 31,2014 July 31,2015 July31, 2016 Medical Imaging GAAP Income From Operations Shore sation expense “ax refund related cha GAAP Income From Operations " Percentage